A reduced expression of CREB and CaMKII observed in our study is indicative of inhibition of neurite growth and compromised synaptic plasticity as reported previously for AD wherein downregulation of CREB inhibited neurite growth [78] and dysregulation of CAMKII altered synaptic plasticity [79]. This evidence concerns the gene CREB1 and Alzheimer disease.